臺北醫學大學附設醫院

Medicine & Life Sciences

1. Anti-Inflammatory Agents 8%
2. Antioxidants 7%
3. Apoptosis 22%
4. Arsenic 9%
5. Autophagy 8%
6. Biomarkers 11%
7. Bipolar Disorder 13%
8. Blood Platelets 9%
9. Blood Pressure 7%
10. Bone and Bones 11%
11. Brain 7%
12. Breast Neoplasms 17%
13. Carcinoma 10%
14. Case-Control Studies 11%
15. Catenins 7%
16. Cell Line 8%
17. Cell Movement 8%
18. Cell Proliferation 8%
19. Child 9%
20. Chronic Renal Insufficiency 12%
21. Cohort Studies 30%
22. Colonic Neoplasms 8%
23. Colorectal Neoplasms 15%
24. Comorbidity 7%
25. Confidence Intervals 24%
26. Control Groups 8%
27. Cross-Sectional Studies 7%
28. Cytokines 7%
29. Databases 15%
30. Datasets 8%
31. Depression 7%
32. Down-Regulation 11%
33. Drug Therapy 8%
34. Endothelial Cells 7%
35. ErbB Receptors 7%
36. Fibrosis 8%
37. Gene Expression 9%
38. Genes 14%
39. Glioblastoma 8%
40. Glucose 7%
41. Growth 12%
42. Hepatocellular Carcinoma 16%
43. Hyperoxia 9%
44. Hypertension 8%
45. In Vitro Techniques 13%
46. Incidence 12%
47. Inflammation 14%
48. Kidney 12%
49. Lipopolysaccharides 9%
50. Liver 9%
51. Logistic Models 10%
52. Lung 14%
53. Lung Neoplasms 8%
54. Machine Learning 7%
55. Macrophages 9%
56. Mesenchymal Stem Cells 9%
57. Messenger RNA 8%
58. Meta-Analysis 23%
59. MicroRNAs 7%
60. Mortality 18%
61. Mothers 7%
62. Mutation 7%
63. National Health Programs 12%
64. Neoplasm Metastasis 15%
65. Neoplasms 36%
66. Nitric Oxide 7%
67. Non-Small Cell Lung Carcinoma 8%
68. Obesity 8%
69. Odds Ratio 21%
70. Oxidative Stress 9%
71. Pain 7%
72. Parkinson Disease 7%
73. Pharmaceutical Preparations 9%
74. Phosphorylation 8%
75. Population 35%
76. Pregnancy 8%
77. Propensity Score 7%
78. Prostatic Neoplasms 9%
79. Proteins 15%
80. Quality of Life 7%
81. Radiotherapy 9%
82. Randomized Controlled Trials 14%
83. Reactive Oxygen Species 8%
84. Recurrence 8%
85. Renal Dialysis 10%
86. Retrospective Studies 12%
87. Robotics 8%
88. Sepsis 7%
89. Serum 13%
90. Sleep 7%
91. Squamous Cell Carcinoma 7%
92. Stem Cells 8%
93. Stroke 25%
94. Survival 12%
95. Systematic Reviews 17%
96. Taiwan 100%
97. Therapeutics 27%
98. Traumatic Brain Injury 10%
99. Up-Regulation 8%
100. Wounds and Injuries 17%